Delivery Order SPE2DB22D2005-SPE2DB25FJHN2
Award Date
2/17/25
Potential Completion Date
2/18/25
Potential Value
$4.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,366.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NALBUPHINE 200 MG/10 ML VIAL 10ML medical supplies, with a performance period ending on December 15, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NALBUPHINE 200 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $1,887.80 and a completion date of February 3, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This federal contract award, valued at $2,737.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of 4562194143 - NALBUPHINE 200 MG/10 ML VIAL 10ML, with a completion date of September 18, 2023. The contract type is Firm Fixed Price. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, with a ceiling value of $1,270.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order and has a Firm Fixed Price pricing type, with an ultimate completion date of February 24, 2025. The contract is for the supply of NALBUPHINE 100 MG/10 ML VIAL 10ML, a pharmaceutical product. This award is not designated as a set-aside contract....
This federal contract award, valued at $3,498.93, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of NALBUPHINE 100 MG/10 ML VIAL 10ML, a pharmaceutical product, with a performance period ending on December 20, 2024. The contract is structured as a Firm Fixed Price Delivery Order and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,971.45 firm fixed-price delivery order is for the supply of NALBUPHINE 100 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has a completion date of February 4, 2025 and was awarded on February 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $2,036.86 for the supply of NALBUPHINE 100 MG/10 ML VIAL 10ML. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 18, 2025, with a completion date of February 19, 2025. This contract represents a small portion of Amerisourcebergen's broader contracting relationship with the federal government, as the company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,909.85 firm fixed-price delivery order is for the supply of 4565897017 - NALBUPHINE 100 MG/10 ML VIAL 10ML, with a period of performance through September 23, 2024. This contract is not associated with any set-aside requirements. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,558.95 firm fixed-price delivery order contract is for the supply of NALBUPHINE 20 MG/ML AMPULML, a pharmaceutical product. The contract has a period of performance through February 20, 2025. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,228.36 firm-fixed-price delivery order is for the supply of 4,565,119,617 units of the prescription medication Nalbuphine 100 mg/10 ml vial. The contract has a completion date of July 12, 2024 and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...